Ranch Capital Advisors Inc. Pfizer Inc Transaction History

Ranch Capital Advisors Inc.

$255 Million
Q3 2025

A detailed history of Ranch Capital Advisors Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Ranch Capital Advisors Inc. holds 69,951 shares of PFE stock, worth $1.75 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

69,951

Previous 12,789 446.96%

Holding current value

$1.75 Million

Previous $310,000 474.84%

% of portfolio

0.7%

Previous 0.14%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$23.29 - $25.88 $1.33 Million - $1.48 Million	57,162 Added 446.96%	69,951 $1.78 Million
Q2 2025 Jul 31, 2025	SELL	$21.59 - $24.84 $11,118 - $12,792	-515 Reduced 3.87%	12,789 $310,000
Q1 2025 May 09, 2025	BUY	$25.01 - $27.13 $8,128 - $8,817	325 Added 2.5%	13,304 $337,000
Q4 2024 Feb 07, 2025	SELL	$24.8 - $30.19 $11,085 - $13,494	-447 Reduced 3.33%	12,979 $344,000
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $12,963 - $14,690	468 Added 3.61%	13,426 $388,000

Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $7,830 - $9,176	-310 Reduced 2.34%	12,958 $362,000
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $16,776 - $19,265	-648 Reduced 4.66%	13,268 $368,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $13,613 - $17,682	-521 Reduced 3.61%	13,916 $400,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $37,320 - $43,624	-1,163 Reduced 7.46%	14,437 $478,000
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $28,426 - $32,888	-787 Reduced 4.8%	15,600 $572,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $125,260 - $163,070	-3,180 Reduced 16.25%	16,387 $668,000
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $9,686 - $12,644	-232 Reduced 1.17%	19,567 $1 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $39,252 - $47,917	-897 Reduced 4.33%	19,799 $866,000
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $4,048 - $4,799	-87 Reduced 0.42%	20,696 $1.09 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $45,292 - $56,123	-990 Reduced 4.55%	20,783 $1.08 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $11,652 - $17,272	-282 Reduced 1.28%	21,773 $1.29 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $18,369 - $23,596	-468 Reduced 2.08%	22,055 $949,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $4,416 - $5,003	123 Added 0.55%	22,523 $882,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $46,785 - $52,764	-1,397 Reduced 5.87%	22,400 $811,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $29,085 - $36,984	869 Added 3.79%	23,797 $875,000
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $14,128 - $16,576	-445 Reduced 1.9%	22,928 $858,000
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $14,547 - $17,648	-483 Reduced 2.02%	23,373 $897,000
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $70,305 - $100,450	-2,601 Reduced 9.83%	23,856 $778,000
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $77,559 - $88,020	-2,356 Reduced 8.18%	26,457 $1.04 Million
Q3 2019 Nov 18, 2019	BUY	$32.49 - $42.13 $936,134 - $1.21 Million	28,813 New	28,813 $1.04 Million

Others Institutions Holding PFE

# of Institutions

3,354

Shares Held

3.56B

Call Options Held

87.2M

Put Options Held

106M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ranch Capital Advisors Inc. with notifications on news.

Account

Ranch Capital Advisors Inc. Pfizer Inc Transaction History